Skip to main content

Table 4 Adverse event incidence by age group, PZQ 40 mg/kg

From: Efficacy and safety of praziquantel 40 mg/kg in preschool-aged and school-aged children: a meta-analysis

Adverse event

Pre-school aged

School-aged

No. of study arms

No. of subjects

Incidence (95% CI)

No. of study arms

No. of subjects

Incidence (95% CI)

%

Lower bound

Upper bound

%

Lower bound

Upper bound

Any adverse event (at least one)

1

243

34.2

28.2

40.2

8

1,342

54.2

37.0

72.2

Drowsiness

2

503

29.1

28.0

30.1

2

285

42.4

35.8

49.0

Dizziness

3

737

22.4

1.3

33.9

13

3,132

9.3

5.4

14.1

Fatigue

3

737

13.3

0.9

20.9

3

781

13.2

0.4

28.9

Itching/rash

2

503

8.6

8.0

9.1

8

1,504

5.5

2.3

9.3

Nausea

3

737

7.8

2.1

12.6

12

3,058

12.9

6.4

20.2

Abdominal pain

3

737

7.2

3.0

9.4

19

3,495

33.4

22.6

43.9

Vomiting

3

737

6.8

1.7

9.6

15

2,911

7.9

3.8

13.2

Headache

3

737

4.4

0.4

6.7

17

3,314

16.6

9.8

24.0

Diarrhoea

3

737

4.3

2.6

6.3

16

3,106

12.1

6.5

19.3

  1. Abbreviations: CI confidence interval